Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMMAD KHAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1427010685
CMS profile
291665
Location
LAKE CHARLES, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,958.45

106 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,838.92 103
Education $119.53 3

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMMAD KHAN

NPI 1427010685 · CMS profile ID 291665

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LAKE CHARLES, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427010685?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMMAD KHAN, NPI 1427010685, CMS profile ID 291665. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427010685?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MOHAMMAD KHAN, NPI 1427010685, CMS profile ID 291665. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427010685?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MOHAMMAD KHAN, NPI 1427010685, CMS profile ID 291665, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 106 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1427010685?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

106 matching records · $1,958.45 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 106 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 106.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Astellas Pharma US Inc $17.1908/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940243423 CMS
Aurinia Pharma U.S., Inc. $14.9008/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954085923 CMS
Celgene Corporation $22.0908/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751541 CMS
GENZYME CORPORATION $18.2808/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938884883 CMS
Merck Sharp & Dohme LLC $21.5208/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944597475 CMS
Amgen Inc. $17.0608/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939842343 CMS
ARRAY BIOPHARMA INC $12.0807/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949352461 CMS
Daiichi Sankyo Inc. $18.3407/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930818011 CMS
GlaxoSmithKline, LLC. $24.5607/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945016263 CMS
Celgene Corporation $10.6807/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751527 CMS
Aurinia Pharma U.S., Inc. $25.7107/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954085919 CMS
Astellas Pharma US Inc $16.9207/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940219535 CMS
Celgene Corporation $15.0106/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751523 CMS
Celgene Corporation $2.1206/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751519 CMS
Celgene Corporation $13.7806/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751521 CMS
Novartis Pharmaceuticals Corporation $17.2406/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829763 CMS
Global Blood Therapeutics, Inc. $20.8706/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942704033 CMS
E.R. Squibb & Sons, L.L.C. $14.6106/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751525 CMS
Amgen Inc. $10.6006/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939206113 CMS
Lilly USA, LLC $18.4606/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918207647 CMS
Amgen Inc. $11.8205/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939206111 CMS
Celgene Corporation $13.4205/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751517 CMS
Merck Sharp & Dohme LLC $21.9005/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944575029 CMS
AstraZeneca Pharmaceuticals LP $14.4105/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914950793 CMS
Celgene Corporation $8.4305/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751515 CMS
GlaxoSmithKline, LLC. $33.2804/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945016265 CMS
Janssen Pharmaceuticals, Inc $15.9004/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 886330073 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.2004/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955682769 CMS
PFIZER INC. $15.0704/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949111065 CMS
Janssen Biotech, Inc. $12.8004/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885959585 CMS
Coherus Biosciences Inc. $12.8503/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956563499 CMS
Janssen Biotech, Inc. $14.5003/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885959591 CMS
Merck Sharp & Dohme LLC $20.8403/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944575553 CMS
Amgen Inc. $22.3503/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939842341 CMS
Global Blood Therapeutics, Inc. $17.4003/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942704029 CMS
GlaxoSmithKline, LLC. $27.7803/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945016261 CMS
E.R. Squibb & Sons, L.L.C. $15.2003/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932751505 CMS
Astellas Pharma US Inc $15.1803/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940139507 CMS
Amgen Inc. $16.4302/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939206115 CMS
Amgen Inc. $19.4302/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939842349 CMS
PUMA BIOTECHNOLOGY, INC. $19.4602/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942298537 CMS
Merck Sharp & Dohme LLC $19.2202/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944577441 CMS
Merck Sharp & Dohme LLC $10.8502/17/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944600221 CMS
Daiichi Sankyo Inc. $24.1602/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930806513 CMS
Janssen Biotech, Inc. $25.8502/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885959579 CMS
Novartis Pharmaceuticals Corporation $18.8402/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829759 CMS
Astellas Pharma US Inc $12.0102/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940118357 CMS
Lilly USA, LLC $16.6302/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918251903 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.7301/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 955682765 CMS
Lilly USA, LLC $17.6601/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918243713 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $838.16 51
PY2020 $341.56 17
PY2021 $972.43 53
PY2022 $1,958.45 106
PY2023 $2,353.87 123
PY2024 $2,018.41 94
PY2025 $2,214.43 101

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $2,231.50 9
PY2022 Recipient $257.00 1
PY2022 Principal investigator $2,185.10 17
PY2021 Recipient $14,061.00 2
PY2021 Principal investigator $3,454.23 15
PY2020 Principal investigator $21,072.49 29
PY2019 Principal investigator $25,899.40 52

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Incyte Corporation $90.25 08/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816793
Principal investigator 1 Incyte Corporation $90.25 07/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816781
Principal investigator 1 Incyte Corporation $90.25 06/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816769
Principal investigator 1 Incyte Corporation $90.25 05/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816755
Principal investigator 1 Incyte Corporation $90.25 04/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816729
Principal investigator 1 Incyte Corporation $90.25 03/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816717
Principal investigator 1 Incyte Corporation $95.00 02/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816705
Principal investigator 1 Eli Lilly and Company $1,500.00 01/09/2023 Non-covered Recipient Entity
CARE ACCESS RESEARCH LLC
EMONARCHER: A RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE 3 STUDY OF ABEMACICLIB PLUS STANDARD ADJUVANT ENDOCRINE THERAPY IN PARTICIPANTS WITH HIGH-RISK NODE-POSITIVE HR+ HER2+ EARLY BREAST CANCER WHO HAVE COMPLETED ADJUVANT HER2-TARGETED THERAPY No dispute reported 06/30/2026 1038082545
Principal investigator 1 Incyte Corporation $95.00 01/01/2023 Non-covered Recipient Entity
CLINICAL TRIALS OF SWLA LLC
An Open Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL 203) No dispute reported 06/30/2026 1040816693